JF
PASG icon

Jump Financial’s Passage Bio PASG Stock Holding History

Jump Financial’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,230
Closed -$138K – 1921
2022
Q1 		$138K Buy
2,230
+295
+15% +$24.3K 0.01% 1373
2021
Q4 		$246K Buy
1,935
+300
+18% +$49K 0.02% 1002
2021
Q3 		$326K Buy
1,635
+970
+146% +$231K 0.02% 624
2021
Q2 		$176K Buy
+665
New +$206K 0.02% 902

Other funds holding PASG

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jump Financial's PASG Position: Q2 2022 in Review

Jump Financial sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 2,230 shares — an estimated $138K sold.

Jump Financial first reported a position in PASG in Q2 2021 and held it in 4 quarters. The position peaked at $326K in Q3 2021. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

  • Jump Financial reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
  • Jump Financial sold 2,230 Passage Bio shares in Q2 2022, an estimated $138K.
  • Jump Financial first reported a position in Passage Bio in Q2 2021 and held it in 4 quarters.
  • Jump Financial's Passage Bio position peaked at $326K in Q3 2021.
  • 85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on Jump Financial's 13F filing for Q2 2022, filed 9 Aug 2022.